Home Newsfeeds Sidoti & Co. Downgrades Co-Diagnostics to Neutral, Announces $5 Price Target

Sidoti & Co. Downgrades Co-Diagnostics to Neutral, Announces $5 Price Target

Sidoti & Co. analyst James Sidoti downgrades Co-Diagnostics (NASDAQ:CODX) from Buy to Neutral and announces $5 price target.

byBenzinga Newsdesk

August 12, 2022

1 minute read

Sidoti & Co. analyst James Sidoti downgrades Co-Diagnostics (NASDAQ:CODX) from Buy to Neutral and announces $5 price target.

B. Riley Securities Maintains Buy on City Office REIT, Lowers Price Target to $12

By Benzinga Newsdesk

February 27, 9:44 AM

B. Riley Securities analyst Craig Kucera maintains City Office REIT (NYSE:CIO) with a Buy and lowers the price target from $14 to $12.

CIO

Global
News

Taiwan Shaken By Massive 7.2 Magnitude Earthquake, Forcing TSMC To Suspend Chip Production

By Benzinga Neuro

April 2, 11:57 PM

Taiwan was struck by a powerful 7.2 magnitude earthquake on Wednesday, the strongest in a quarter of a century. The quake has resulted in one fatality, numerous injuries, and significant damage to buildings in the region.

TSM

NextEra Energy Partners Slashes LP Distribution Growth to 5%-8% (Vs Prior 12%-15%) Annually Through at least 2026

By Benzinga Newsdesk

September 27, 6:38 AM

NextEra Energy Partners, LP (NYSE:NEP) today announced that it is revising its growth rate to better position the partnership to continue to deliver long-term value for unitholders. The partnership is revising its

NEP